Classificação em ações
#28270
Syntara Limited is a clinical-stage biopharmaceutical company dedicated to... Syntara Limited is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies by targeting extracellular matrix dysfunction, primarily through amine oxidase chemistry. Headquartered in Frenchs Forest, Australia, the company's research pipeline focuses on blood cancers as well as a range of inflammatory and fibrotic disorders. Its leading investigational compound, amsulostat, is currently in Phase 1c/2 clinical trials for the treatment of myelofibrosis, a bone marrow cancer, and is also being evaluated for myelodysplastic syndrome. Beyond this, Syntara is advancing several other promising drug candidates. These include a suite of topical pan-LOX inhibitors: SNT-9465, which is undergoing Phase 1a/b study for hypertrophic scars, and SNT-6302, designed for keloid scars. Furthermore, SNT-4728 is in development to manage sleep disorders and to potentially slow the progression of neurodegenerative conditions by mitigating neuroinflammation. The company's broader therapeutic ambitions extend to various fibrotic and inflammatory diseases such as kidney fibrosis, MASH (metabolic dysfunction-associated steatohepatitis), pulmonary fibrosis, and cardiac fibrosis. Incorporated in 1998, the company was formerly known as Pharmaxis Ltd before adopting the name Syntara Limited in December 2023.
Preço da ação
$0.0183374
Última sincronização: 2026-08-19
Negociar Syntara Limited (SNT)
Preço SNT com a capitalização de mercado de B
Capitalização de mercado de Syntara Limited(SNT)
Valor de mercado: $27.51M
Em August 2026, Syntara Limited tem uma capitalização de mercado de $27.51M. Isso faz com que Syntara Limited seja a 28270th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Syntara Limited de 2003 a 2026
SNT comparado com o topo de 5 mais populares stocks
| Preço para SNT |
|
Ativo B |
Capitalização de mercado de B |
Resultados |
|
|
|
|
$5.301T
|
+19,267,682.92%
|
|
|
|
|
$4.634T
|
+16,843,248.04%
|
|
|
|
|
$4.143T
|
+15,058,953.48%
|
|
|
|
|
$3.589T
|
+13,046,679.38%
|
|
|
|
|
$2.857T
|
+10,384,438.20%
|
